Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics-Reference-Cited by-同舟云学术

Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics

Published:2019 Issue:7 Volume:10 Page:1068-1081
ISSN:2040-2503
Container-title:MedChemComm
language:en
Short-container-title:Med. Chem. Commun.

Author:

Zorzi Alessandro¹²³⁴⁵^ORCID,Linciano Sara⁶⁷⁸⁹^ORCID,Angelini Alessandro⁶⁷⁸⁹¹⁰^ORCID

Affiliation:

1. Institute of Chemical Sciences and Engineering

2. School of Basic Sciences

3. Ecole Polytechnique Fédérale de Lausanne (EPFL)

4. Lausanne CH-1015

5. Switzerland

6. Department of Molecular Sciences and Nanosystems

7. Ca' Foscari University of Venice

8. Venezia Mestre 30172

9. Italy

10. European Centre for Living Technologies (ECLT)

Abstract

This review provides a detailed examination and comparison of the diverse non-covalent albumin-binding ligands developed until now to extend the half-life of different small biotherapeutics.

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/MD/C9MD00018F

Reference102 articles.

1. Challenges and opportunities for non-antibody scaffold drugs

2. Emerging Strategies for Developing Next-Generation Protein Therapeutics for Cancer Treatment

3. The Current State of Peptide Drug Discovery: Back to the Future?

4. Pharmacokinetics of Toxin-Derived Peptide Drugs

5. Half-life extended biotherapeutics

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-affinity-pharmacokinetics relationships of 111In-labeled PSMA-targeted ligands with different albumin binders;Nuclear Medicine and Biology;2024-11

2. Metabolic phenotyping combined with transcriptomics metadata fortifies the diagnosis of early-stage Hepatocellular carcinoma;Journal of Advanced Research;2024-09

3. Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate;Nature Communications;2024-08-30

4. Thermal effects and drugs competition on the palmitate binding capacity of human serum albumin;Biochemical and Biophysical Research Communications;2024-08

5. Stimulating the Antitumor Immune Response Using Immunocytokines: A Preclinical and Clinical Overview;Pharmaceutics;2024-07-24